Synthetic Blood Substitute Market Demand, Size and Competitive Analysis | TechSci Research

Global Synthetic Blood Substitute Market was valued at USD 8.61 Million in 2023 and is expected to reach USD 15.04 Million by 2029 with a CAGR of 9.92% during the forecast period. <table><tr><td>Pages</td><td>183</td></tr> <tr><td>Market Size</td><td>2023: USD 8.61 Million</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 15.04 Million</td></tr> <tr><td>CAGR</td><td>2024-2029: 9.92%</td></tr> <tr><td>Fastest Growing Segment</td><td>Cardiovascular Diseases</td></tr> <tr><td>Largest Market</td><td>North America</td></tr> <tr><td>Key Players</td><td>1.Aurum Biosciences Ltd2.Hemarina SA3.Hemoglobin Oxygen Therapeutics LLC4.SpheriTech Ltd5.Kalocyte, Inc.6.OPKO Health, Inc.7.Prolong Pharmaceuticals, LLC8.VisusMed Medical Center9.Boston Pharmaceuticals, Inc</td></tr> </table>

全球合成血液代用品市场在2023年估值达到8.61亿美元，预计在预测期内将以9.92%的复合年增长率增长，并于2029年达到15.04亿美元的规模。

<table>
<tr><td>页数</td><td>183</td></tr>
<tr><td>市场规模</td><td>2023年：8.61亿美元</td></tr>
<tr><td>预测市场规模</td><td>2029年：15.04亿美元</td></tr>
<tr><td>复合年增长率</td><td>2024-2029年：9.92%</td></tr>
<tr><td>增长最快的细分市场</td><td>心血管疾病</td></tr>
<tr><td>最大市场</td><td>北美</td></tr>
<tr><td>主要参与者</td><td>1. Aurum Biosciences Ltd 2. Hemarina SA 3. Hemoglobin Oxygen Therapeutics LLC 4. SpheriTech Ltd 5. Kalocyte, Inc. 6. OPKO Health, Inc. 7. Prolong Pharmaceuticals, LLC 8. VisusMed Medical Center 9. Boston Pharmaceuticals, Inc</td></tr>
</table>